Drysdale, K. (2021). ‘Scene’ as a critical framing device: extending analysis of chemsex cultures. Sexualities. https://doi.org/10.1177/1363460721995467
Drysdale, K., Bryant, J., Dowsett, G. W., Lea, T., Treloar, C., Aggleton, P., & Holt, M. (2021). Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2021.103163
Drysdale, K. Bryant, J., Hopwood, M., Dowsett, GW, Holt, M., Lea, T., Aggelton, P., and Treloar, C. (2020). “Destabilising the ‘problem’ of chemsex: diversity in settings, relations and practices revealed in Australian gay and bisexual men’s crystal methamphetamine use”, International Journal of Drug Policy. Online 14 February 2020. https://doi.org/10.1016/j.drugpo.2020.102697
Bryant J, Hopwood M, Dowsett G.W., Aggleton P, Holt M, Lea T, Drysdale K, Treloar C (2018). The rush to risk when interrogating the relationship between methamphetamine use and sexual practice among gay and bisexual men. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2017.12.010
Dowsett, G.W., et al. (2005). Good gay men don’t get “messy”: Injecting drug use and gay community. Sexuality Research and Social Policy. 2(2): 22-36. http://doi.org/10.1007/s10461-013-0409-
Hopwood, M., Cama, E., & Treloar, C. (2016). Methamphetamine use among men who have sex with men in Australia: A literature review. Sydney: Centre for Social Research in Health, UNSW Australia. http://doi.org/10.4225/53/58d4418d0a14b
Hopwood, M., Drysdale, K., & Treloar, C. (2018). ‘Sunshine on a rainy day’: Crystal methamphetamine use among gay and bisexual men in Perth. Sydney: Centre for Social Research in Health, Sydney. http://doi.org/10.26190/5be39b00ad585
Hopwood, M., Lea T., & Aggleton, P. (2015). Multiple strategies are required to address the information and support needs of gay and bisexual men with hepatitis C in Australia. Journal of Public Health, 38 (1): 156-162. http://doi.org/10.1093/pubmed/fdv002
Hopwood, M., Lea, T., & Aggleton, P. (2015). Drug, sex and sociality: Factors associated with the recent sharing of injecting equipment among gay and bisexual men in Australia. International Journal of Drug Policy. 26(2), 210-213. http://doi.org/10.1016/j.drugpo.2014.10.01
Hopwood, M., & Treloar, C. (2013). International policies to reduce illicit drug-related harm and illicit drug use. In P. Miller (Ed.), Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders, Volume 3 (pp. 735-743), Elsevier Inc. San Diego: Academic Press.
Lea, T. Hopwood, M., & Aggleton, P. (2015). Hepatitis C knowledge among gay and other homosexually active men in Australia. Drug and Alcohol Review, 35(4), 477–483. http://doi.org/10.1111/dar.1233
Lea, T., Mao, L., Hopwood, M., Prestage, G., Zablotska, I., de Wit, J., & Holt, M. (2016). Methamphetamine use among gay and bisexual men in Australia: trends in recent and regular use from the Gay Community Periodic Surveys. International Journal of Drug Policy, 29 (1), 66-72. http://doi.org/10.1016/j.drugpo.2016.01.003
Lea, T., Mao, L., Bath, N., Prestage, G., Zablotska, I., de Wit, J. & Holt, M. (2013). Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection. AIDS & Behavior, 17(4), 1344-1351. http://doi.org/10.1007/s10461-013-0409-0
Lea, T., Kolstee, J., Lambert, S., Ness, R., Hannan, S., & Holt, M. (2017). Methamphetamine treatment outcomes among clients attending a treatment service for lesbian, gay, bisexual and transgender people. PLOS ONE, 12(2): e0172560. http://doi.org/10.1371/journal.pone.017256
Southgate, E., & Hopwood, M. (1999). Mardi Gras says ‘be drug free’: Accounting for resistance, pleasure and the demand for illicit drugs. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 3, 303-316.
Southgate, E., & Hopwood, M. (2001). The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy, 12, 321-335.